Groner, B <br/><br/>
Intra-tumoral application of a heregulin-exotoxin-a fusion protein causes rapid tumor regression without adverse systemic or local effects.  [electronic resource] 

 -  International journal of cancer  Mar 1997 
 - 682-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0215(19970317)70:6<682::aid-ijc10>3.0.co;2-c  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Breast Neoplasms--drug therapy<br/>Carcinoma--drug therapy<br/>Carrier Proteins--pharmacology<br/>Exotoxins--pharmacology<br/>Female<br/>Glycoproteins--pharmacology<br/>Liver--drug effects<br/>Mice<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Neoplasms, Experimental--drug therapy<br/>Neuregulin-1<br/>Rats<br/>Recombinant Fusion Proteins--pharmacology